Salvador Oyonarte
Research Subjects
Salvador Oyonarte has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
- Juan Sainz
Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, 18071 Granada, Spain
4 shared publications A. Fernández Montoya
Centro Regional de Transfusión Sanguínea de Granada‐Almeria, Granada, Spain
2 shared publicationsC. Bianco
2 shared publications- Carlos Daniel de La Vega Elena
Servicio de Medicina Transfusional, Hospital Italiano Garibaldi, Rosario, Argentina
2 shared publications E. López-Fernández
Haematology Department, Virgen de las Nieves University Hospital, Granada
2 shared publicationsE. Muñiz‐Díaz
Banc de Sang i Teixits, Barcelona, Spain
2 shared publications
Latest Publications
- Open Access
- 5 April 2018
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 23 (14) , 17-00261-9
West Nile virus outbreak in humans and epidemiological surveillance, west Andalusia, Spain, 2016
In Andalusia, Spain, West Nile virus (WNV) surveillance takes place from April to November, during the active vector period. Within this area seroconversion to this virus was evidenced in wild birds in 2004, affecting horses and two humans for the first time in 2010. Since 2010, the virus has been isolated every year in horses, and national and regional surveillance plans have been updated with the epidemiological changes found. WNV is spreading rapidly throughout southern Europe and has caused outbreaks in humans. Here we describe the second WNV outbreak in humans in Andalusia, with three confirmed cases, which occurred between August and September 2016, and the measures carried out to control it. Surveillance during the transmission season is essential to monitor and ensure prompt identification of any outbreaks.
- 5 April 2018
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 23 (14) , 17-00261-9
Open AccessWest Nile virus outbreak in humans and epidemiological surveillance, west Andalusia, Spain, 2016
In Andalusia, Spain, West Nile virus (WNV) surveillance takes place from April to November, during the active vector period. Within this area seroconversion to this virus was evidenced in wild birds in 2004, affecting horses and two humans for the first time in 2010. Since 2010, the virus has been isolated every year in horses, and national and regional surveillance plans have been updated with the epidemiological changes found. WNV is spreading rapidly throughout southern Europe and has caused outbreaks in humans. Here we describe the second WNV outbreak in humans in Andalusia, with three confirmed cases, which occurred between August and September 2016, and the measures carried out to control it. Surveillance during the transmission season is essential to monitor and ensure prompt identification of any outbreaks.
- 20 March 2017
- Published by Wiley in Vox Sanguinis
- Vol. 112 (4) , e1-e21
Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion‐transmissible infections
- 20 March 2017
- Published by Wiley in Vox Sanguinis
- Vol. 112 (4) , e1-e21
Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion‐transmissible infections
- 20 March 2017
- Published by Wiley in Vox Sanguinis
- Vol. 112 (4) , 388-396
Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion‐transmissible infections: summary
- 20 March 2017
- Published by Wiley in Vox Sanguinis
- Vol. 112 (4) , 388-396
Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion‐transmissible infections: summary
- 1 July 2016
- Published by Elsevier in Cytotherapy
- Vol. 18 (7) , 809-815
Cell-based product classification procedure: What can be done differently to improve decisions on borderline products?
- 1 July 2016
- Published by Elsevier in Cytotherapy
- Vol. 18 (7) , 809-815
Cell-based product classification procedure: What can be done differently to improve decisions on borderline products?
- Open Access
- 27 February 2012
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (2) , e32273
Dectin-1 and DC-SIGN Polymorphisms Associated with Invasive Pulmonary Aspergillosis Infection
The recognition of pathogen-derived structures by C-type lectins and the chemotactic activity mediated by the CCL2/CCR2 axis are critical steps in determining the host immune response to fungi. The present study was designed to investigate whether the presence of single nucleotide polymorphisms (SNPs) within DC-SIGN, Dectin-1, Dectin-2, CCL2 and CCR2 genes influence the risk of developing Invasive Pulmonary Aspergillosis (IPA). Twenty-seven SNPs were selected using a hybrid functional/tagging approach and genotyped in 182 haematological patients, fifty-seven of them diagnosed with proven or probable IPA according to the 2008 EORTC/MSG criteria. Association analysis revealed that carriers of the Dectin-1rs3901533 T/T and Dectin-1rs7309123 G/G genotypes and DC-SIGNrs4804800 G, DC-SIGNrs11465384 T, DC-SIGN7248637 A and DC-SIGN7252229 C alleles had a significantly increased risk of IPA infection (OR = 5.59 95%CI 1.37–22.77; OR = 4.91 95%CI 1.52–15.89; OR = 2.75 95%CI 1.27–5.95; OR = 2.70 95%CI 1.24–5.90; OR = 2.39 95%CI 1.09–5.22 and OR = 2.05 95%CI 1.00–4.22, respectively). There was also a significantly increased frequency of galactomannan positivity among patients carrying the Dectin-1rs3901533_T allele and Dectin-1rs7309123_G/G genotype. In addition, healthy individuals with this latter genotype showed a significantly decreased level of Dectin-1 mRNA expression compared to C-allele carriers, suggesting a role of the Dectin-1rs7309123 polymorphism in determining the levels of Dectin-1 and, consequently, the level of susceptibility to IPA infection. SNP-SNP interaction (epistasis) analysis revealed significant interactions models including SNPs in Dectin-1, Dectin-2, CCL2 and CCR2 genes, with synergistic genetic effects. Although these results need to be further validated in larger cohorts, they suggest that Dectin-1, DC-SIGN, Dectin-2, CCL2 and CCR2 genetic variants influence the risk of IPA infection and might be useful in developing a risk-adapted prophylaxis.
- 27 February 2012
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (2) , e32273
Open AccessDectin-1 and DC-SIGN Polymorphisms Associated with Invasive Pulmonary Aspergillosis Infection
The recognition of pathogen-derived structures by C-type lectins and the chemotactic activity mediated by the CCL2/CCR2 axis are critical steps in determining the host immune response to fungi. The present study was designed to investigate whether the presence of single nucleotide polymorphisms (SNPs) within DC-SIGN, Dectin-1, Dectin-2, CCL2 and CCR2 genes influence the risk of developing Invasive Pulmonary Aspergillosis (IPA). Twenty-seven SNPs were selected using a hybrid functional/tagging approach and genotyped in 182 haematological patients, fifty-seven of them diagnosed with proven or probable IPA according to the 2008 EORTC/MSG criteria. Association analysis revealed that carriers of the Dectin-1rs3901533 T/T and Dectin-1rs7309123 G/G genotypes and DC-SIGNrs4804800 G, DC-SIGNrs11465384 T, DC-SIGN7248637 A and DC-SIGN7252229 C alleles had a significantly increased risk of IPA infection (OR = 5.59 95%CI 1.37–22.77; OR = 4.91 95%CI 1.52–15.89; OR = 2.75 95%CI 1.27–5.95; OR = 2.70 95%CI 1.24–5.90; OR = 2.39 95%CI 1.09–5.22 and OR = 2.05 95%CI 1.00–4.22, respectively). There was also a significantly increased frequency of galactomannan positivity among patients carrying the Dectin-1rs3901533_T allele and Dectin-1rs7309123_G/G genotype. In addition, healthy individuals with this latter genotype showed a significantly decreased level of Dectin-1 mRNA expression compared to C-allele carriers, suggesting a role of the Dectin-1rs7309123 polymorphism in determining the levels of Dectin-1 and, consequently, the level of susceptibility to IPA infection. SNP-SNP interaction (epistasis) analysis revealed significant interactions models including SNPs in Dectin-1, Dectin-2, CCL2 and CCR2 genes, with synergistic genetic effects. Although these results need to be further validated in larger cohorts, they suggest that Dectin-1, DC-SIGN, Dectin-2, CCL2 and CCR2 genetic variants influence the risk of IPA infection and might be useful in developing a risk-adapted prophylaxis.
- Open Access
- 1 April 2010
- Published by SAGE Publications in International Journal of Immunopathology and Pharmacology
- Vol. 23 (2) , 423-436
TNFR1 mRNA Expression Level and TNFR1 Gene Polymorphisms are Predictive Markers for Susceptibility to Develop Invasive Pulmonary Aspergillosis
Tumour necrosis factor (TNF) is primarily secreted by monocytes/macrophages and activated T lymphocytes in response to fungal infections. TNF acts through TNF receptor 1 (TNFR1) triggering a pro-inflammatory response, and therefore plays a pivotal role in immune regulation and host immune responses. We hypothesized that single nucleotide polymorphisms (SNPs) in TNFR1 gene may influence the innate immune response against Aspergillus. Three SNPs were genotyped in 275 individuals (144 immunocompromised haematological patients with high-risk of developing IPA and 131 healthy controls): TNFR1-383(A/C) (rs2234649) and TNFR1-609(G/T) (rs4149570) in the 5′ UTR region, and TNFR1+36(A/G) SNP (rs767455) in the first exon of the gene. Of the 144 haematological patients, 77 patients developed Invasive Pulmonary Aspergillosis (IPA) infection and the remaining 67 patients were not infected. TNFR1+36(A/G) and TNFR1-609(G/T) were associated with IPA susceptibility (p=0.033 and p=0.018, respectively). A role of TNFR1 genetic variants in the susceptibility of patients to develop IPA was also supported by the significantly lower TNFR1 mRNA expression level in IPA than in IPA-resistant patients and the strong correlation between the TNFR1-609 genetic variant and the expression levels of TNFR1. There was also a tendency for a higher frequency of galactomannan (GM) positivity in patients with TNFR1-609G/G genotype than in patients with TNFR1-609G/T (p=0.0909) or TNFR1-609T/T (p=0.0913) genotype. Predictive sequence analysis of the effects of TNFR1-609 promoter polymorphism revealed that this SNP might play a critical role in modifying the affinity of ICSBP/IRF-8, a transcription factor that is involved in the TNFR1-mediated activation of NFκB signalling pathway. Taken together, these data suggest that TNFR1 polymorphisms influence the risk of IPA disease and might be useful for risk stratification strategies. These findings need to be confirmed in validation studies with larger samples of haematological patients.
- 1 April 2010
- Published by SAGE Publications in International Journal of Immunopathology and Pharmacology
- Vol. 23 (2) , 423-436
Open AccessTNFR1 mRNA Expression Level and TNFR1 Gene Polymorphisms are Predictive Markers for Susceptibility to Develop Invasive Pulmonary Aspergillosis
Tumour necrosis factor (TNF) is primarily secreted by monocytes/macrophages and activated T lymphocytes in response to fungal infections. TNF acts through TNF receptor 1 (TNFR1) triggering a pro-inflammatory response, and therefore plays a pivotal role in immune regulation and host immune responses. We hypothesized that single nucleotide polymorphisms (SNPs) in TNFR1 gene may influence the innate immune response against Aspergillus. Three SNPs were genotyped in 275 individuals (144 immunocompromised haematological patients with high-risk of developing IPA and 131 healthy controls): TNFR1-383(A/C) (rs2234649) and TNFR1-609(G/T) (rs4149570) in the 5′ UTR region, and TNFR1+36(A/G) SNP (rs767455) in the first exon of the gene. Of the 144 haematological patients, 77 patients developed Invasive Pulmonary Aspergillosis (IPA) infection and the remaining 67 patients were not infected. TNFR1+36(A/G) and TNFR1-609(G/T) were associated with IPA susceptibility (p=0.033 and p=0.018, respectively). A role of TNFR1 genetic variants in the susceptibility of patients to develop IPA was also supported by the significantly lower TNFR1 mRNA expression level in IPA than in IPA-resistant patients and the strong correlation between the TNFR1-609 genetic variant and the expression levels of TNFR1. There was also a tendency for a higher frequency of galactomannan (GM) positivity in patients with TNFR1-609G/G genotype than in patients with TNFR1-609G/T (p=0.0909) or TNFR1-609T/T (p=0.0913) genotype. Predictive sequence analysis of the effects of TNFR1-609 promoter polymorphism revealed that this SNP might play a critical role in modifying the affinity of ICSBP/IRF-8, a transcription factor that is involved in the TNFR1-mediated activation of NFκB signalling pathway. Taken together, these data suggest that TNFR1 polymorphisms influence the risk of IPA disease and might be useful for risk stratification strategies. These findings need to be confirmed in validation studies with larger samples of haematological patients.
- 14 April 2008
- Published by Wiley in Tissue Antigens
- Vol. 71 (5) , 475-477
HNA‐1a, HNA‐1b and HNA‐1c gene frequencies in Argentineans
Human neutrophil antigens (HNA) are polymorphic structures located in the neutrophil membrane. The neutrophil‐specific antigens HNA‐1a (NA1), 1b (NA2) and 1c (SH) are well‐recognized allotypic forms of FcγRIIIb and the most frequent targets of neutrophil alloantibodies. The aim of this study was to determine the gene frequencies of the neutrophil‐specific antigens belonging to the HNA‐1 system in blood donors and Toba Amerindians from Rosario, Argentina. Two hundred and eighteen unrelated healthy Argentinean blood donors and Toba Amerindians from Rosario were typed for HNA‐1a, HNA‐1b and HNA‐1c using polymerase chain reaction with sequence‐specific primers. For the Argentinean blood donors, the HNA‐1a and HNA‐1b gene frequencies were 0.44 and 0.56 and for the Amerindians Toba were 0.77 and 0.23, respectively. The HNA‐1c antigen is present in 4.7% (gene frequency = 0.023) of the blood donors but in none of the Amerindian individuals. The present data showed that the HNA‐1 allele frequencies in the major population and the Toba Amerindians from Rosario are similar to those described in European and others distant Amerindians populations, respectively.
- 14 April 2008
- Published by Wiley in Tissue Antigens
- Vol. 71 (5) , 475-477
HNA‐1a, HNA‐1b and HNA‐1c gene frequencies in Argentineans
Human neutrophil antigens (HNA) are polymorphic structures located in the neutrophil membrane. The neutrophil‐specific antigens HNA‐1a (NA1), 1b (NA2) and 1c (SH) are well‐recognized allotypic forms of FcγRIIIb and the most frequent targets of neutrophil alloantibodies. The aim of this study was to determine the gene frequencies of the neutrophil‐specific antigens belonging to the HNA‐1 system in blood donors and Toba Amerindians from Rosario, Argentina. Two hundred and eighteen unrelated healthy Argentinean blood donors and Toba Amerindians from Rosario were typed for HNA‐1a, HNA‐1b and HNA‐1c using polymerase chain reaction with sequence‐specific primers. For the Argentinean blood donors, the HNA‐1a and HNA‐1b gene frequencies were 0.44 and 0.56 and for the Amerindians Toba were 0.77 and 0.23, respectively. The HNA‐1c antigen is present in 4.7% (gene frequency = 0.023) of the blood donors but in none of the Amerindian individuals. The present data showed that the HNA‐1 allele frequencies in the major population and the Toba Amerindians from Rosario are similar to those described in European and others distant Amerindians populations, respectively.
- Open Access
- 8 April 2008
- Published by Wiley in Transfusion Medicine
- Vol. 18 (2) , 83-90
Human platelet‐specific antigens frequencies in the Argentinean population
summary The frequencies of several human platelet antigens (HPAs) vary between different populations and are a major determinant for the prevalence of HPA alloimmunization and its clinical associated entities. The aim of this study was to characterize the allele frequencies of seven HPA systems in two different ethnic groups from the Argentinean city of Rosario, the major population and a minority Amerindian group recently arrived from the north of the country, the Tobas. A total of 192 healthy unrelated individuals from blood donors and hospital staff from the Hospital Italiano Garibaldi and 27 unrelated Toba Amerindians were genotyped for HPA‐1, ‐2, ‐3, ‐4, ‐5, ‐6 and ‐15 systems by polymerase chain reaction with sequence specific primers (PCR‐SSP). The present data showed that the distribution of the HPA alleles among Argentineans from Rosario is quite similar to that reported among Europeans. The frequencies seen in Tobas, although limited by the small number of aboriginal samples studied, are similar to those reported for other Amerindians populations. Statistically significant differences were found for the genotype distribution of HPA‐1, ‐3, ‐5 and ‐15 between both groups, indicating important differences in the potential risk of HPA alloimmunization associated to transfusion and pregnancy. The study of these polymorphisms represents the first step in the elucidation of pathological conditions that are underdiagnosed in our population. It allowed us to establish a panel of characterized blood donors necessary for the serological work out and as a source for compatible platelets transfusion.
- 8 April 2008
- Published by Wiley in Transfusion Medicine
- Vol. 18 (2) , 83-90
Open AccessHuman platelet‐specific antigens frequencies in the Argentinean population
summary The frequencies of several human platelet antigens (HPAs) vary between different populations and are a major determinant for the prevalence of HPA alloimmunization and its clinical associated entities. The aim of this study was to characterize the allele frequencies of seven HPA systems in two different ethnic groups from the Argentinean city of Rosario, the major population and a minority Amerindian group recently arrived from the north of the country, the Tobas. A total of 192 healthy unrelated individuals from blood donors and hospital staff from the Hospital Italiano Garibaldi and 27 unrelated Toba Amerindians were genotyped for HPA‐1, ‐2, ‐3, ‐4, ‐5, ‐6 and ‐15 systems by polymerase chain reaction with sequence specific primers (PCR‐SSP). The present data showed that the distribution of the HPA alleles among Argentineans from Rosario is quite similar to that reported among Europeans. The frequencies seen in Tobas, although limited by the small number of aboriginal samples studied, are similar to those reported for other Amerindians populations. Statistically significant differences were found for the genotype distribution of HPA‐1, ‐3, ‐5 and ‐15 between both groups, indicating important differences in the potential risk of HPA alloimmunization associated to transfusion and pregnancy. The study of these polymorphisms represents the first step in the elucidation of pathological conditions that are underdiagnosed in our population. It allowed us to establish a panel of characterized blood donors necessary for the serological work out and as a source for compatible platelets transfusion.
- 1 February 2008
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 136 (2) , 151-154
Current clinical management of anti-Kell alloimmunization in pregnancy
- 1 February 2008
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 136 (2) , 151-154
Current clinical management of anti-Kell alloimmunization in pregnancy